One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)

导出原文传递

翻译打印收藏纠错

作者： Tamburino, Corrado ^[1] ; Capodanno, Davide ^[2] ; Erglis, Andrejs ^[3] ; Menown, Ian B. A. ^[4] ; Horvath, Ivan G. ^[5] ; Moreno, Raul ^[6] ; Gilbert, Timothy J. ^[7] ; Crowley, James J. ^[8] ; Calabria, Paolo ^[9] ; Allocco, Dominic J. ; Dawkins, Keith D.

作者单位： Craigavon Cardiac Ctr, Craigavon, North Ireland ^[1] Boston Sci Corp, Marlborough, MA USA ^[2] Univ Pecs, Inst Heart, Pecs, Hungary ^[3] Galway Univ Hosp, Galway, Ireland ^[4] Univ Catania, Ferrarotto Hosp, Catania, Italy ^[5] Norfolk & Norwich Univ Hosp NHS Trust, Norwich, Norfolk, England ^[6] Univ Latvia, Pauls Stradins Clin Univ Hosp, Riga, Latvia ^[7] Univ Hosp La Paz, Madrid, Spain ^[8] Osped Misericordia, Grosseto, Italy ^[9]

关键词 drug-eluting stent paclitaxel platinum-chromium

发布时间 2020-02-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交